Summary
For Year 2026-27, Ajooni Biotech reports the following shareholding: Total Promoters at 26.89%, Mutual Fund at 0%, Insurance at 0%, Foreign Institutional Investors at 0%, Domestic Institutional Investors at 0%, and Retail at 73.11%. This breakdown provides a quick snapshot of ownership distribution for Ajooni Biotech in 2026-27.
Ajooni Biotech FAQs
As of 04-2026, the promoter shareholding in Ajooni Biotech stands at 26.89% of the company's total shares. Promoter shareholding represents the ownership stake held by the company's founding members, management, or controlling entities, having a significant influence on the company's strategic direction and operations.
The FII and DII shareholding of Ajooni Biotech is 0% and 0% respectively.
The retail shareholding of the Ajooni Biotech is 73.11%.
Changes in shareholding patterns of Ajooni Biotech can result from stock market transactions, issuance of new shares, buybacks, mergers, acquisitions, or changes in promoter holdings.
Shareholding patterns of Ajooni Biotech are updated quarterly as mandated by regulatory authorities and may also be disclosed during significant corporate events.
The latest shareholding pattern is available on stock exchanges (e.g., NSE, BSE) and the company's official website under investor relations.
